These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 28040277)

  • 1. Microparticles and their role in coronary artery disease.
    Koganti S; Eleftheriou D; Brogan PA; Kotecha T; Hong Y; Rakhit RD
    Int J Cardiol; 2017 Mar; 230():339-345. PubMed ID: 28040277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Microparticles and Coronary Plaque Components Assessed by Virtual Histology Intravascular Ultrasound of the Target Lesion in Patients with Stable Angina.
    Min PK; Cho M; Hong SY; Kim JY; Choi EY; Yoon YW; Lee BK; Hong BK; Rim SJ; Kwon HM
    PLoS One; 2016; 11(1):e0148128. PubMed ID: 26812147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting carotid artery disease and plaque instability from cell-derived microparticles.
    Wekesa AL; Cross KS; O'Donovan O; Dowdall JF; O'Brien O; Doyle M; Byrne L; Phelan JP; Ross MD; Landers R; Harrison M
    Eur J Vasc Endovasc Surg; 2014 Nov; 48(5):489-95. PubMed ID: 25218652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-Derived Microparticles and Acute Coronary Syndromes: Is there a Predictive Role for Microparticles?
    Zacharia E; Zacharias K; Papamikroulis GA; Bertsias D; Miliou A; Pallantza Z; Papageorgiou N; Tousoulis D
    Curr Med Chem; 2020; 27(27):4440-4468. PubMed ID: 31838988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of counterbalance between macrophage migration inhibitory factor and its inhibitor Gremlin-1 in patients with coronary artery disease.
    Müller II; Müller KA; Karathanos A; Schönleber H; Rath D; Vogel S; Chatterjee M; Schmid M; Haas M; Seizer P; Langer H; Schaeffeler E; Schwab M; Gawaz M; Geisler T
    Atherosclerosis; 2014 Dec; 237(2):426-32. PubMed ID: 25463068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echolucent carotid plaques predict future coronary events in patients with coronary artery disease.
    Honda O; Sugiyama S; Kugiyama K; Fukushima H; Nakamura S; Koide S; Kojima S; Hirai N; Kawano H; Soejima H; Sakamoto T; Yoshimura M; Ogawa H
    J Am Coll Cardiol; 2004 Apr; 43(7):1177-84. PubMed ID: 15063426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of carotid plaque neovascularization at contrast-enhanced US to predict coronary events in patients with coronary artery disease.
    Zhu Y; Deng YB; Liu YN; Bi XJ; Sun J; Tang QY; Deng Q
    Radiology; 2013 Jul; 268(1):54-60. PubMed ID: 23440321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of plaque characteristics in narrowings with ST-elevation myocardial infarction (STEMI), non-STEMI/unstable angina pectoris and stable coronary artery disease (from the ADAPT-DES IVUS Substudy).
    Dong L; Mintz GS; Witzenbichler B; Metzger DC; Rinaldi MJ; Duffy PL; Weisz G; Stuckey TD; Brodie BR; Yun KH; Xu K; Kirtane AJ; Stone GW; Maehara A
    Am J Cardiol; 2015 Apr; 115(7):860-6. PubMed ID: 25661569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microparticles as biomarkers of venous thromboembolic events.
    Campello E; Spiezia L; Radu CM; Simioni P
    Biomark Med; 2016 Jul; 10(7):743-55. PubMed ID: 27338783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of plaque echolucency in combination with inflammatory biomarkers on cardiovascular outcomes of coronary artery disease patients receiving optimal medical therapy.
    Ishizu T; Seo Y; Machino T; Kawamura R; Kimura T; Murakoshi N; Sato A; Takeyasu N; Watanabe S; Aonuma K
    Atherosclerosis; 2011 May; 216(1):120-4. PubMed ID: 21353222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between serum levels of total bilirubin and coronary plaque vulnerability.
    Zhu KF; Wang YM; Wang YQ; Wang NF
    Coron Artery Dis; 2016 Jan; 27(1):52-8. PubMed ID: 26444254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent epicardial adipose tissue accumulation is associated with coronary plaque vulnerability and future acute coronary syndrome in non-obese subjects with coronary artery disease.
    Nakanishi K; Fukuda S; Tanaka A; Otsuka K; Jissho S; Taguchi H; Yoshikawa J; Shimada K
    Atherosclerosis; 2014 Nov; 237(1):353-60. PubMed ID: 25310459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA expression profile in human coronary smooth muscle cell-derived microparticles is a source of biomarkers.
    de Gonzalo-Calvo D; Cenarro A; Civeira F; Llorente-Cortes V
    Clin Investig Arterioscler; 2016; 28(4):167-77. PubMed ID: 27363781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophil cationic protein: A new biomarker of coronary atherosclerosis.
    Niccoli G; Ferrante G; Cosentino N; Conte M; Belloni F; Marino M; Bacà M; Montone RA; Sabato V; Schiavino D; Patriarca G; Crea F
    Atherosclerosis; 2010 Aug; 211(2):606-11. PubMed ID: 20307883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Near-infrared spectroscopy for intracoronary detection of lipid-rich plaques to understand atherosclerotic plaque biology in man and guide clinical therapy.
    Erlinge D
    J Intern Med; 2015 Aug; 278(2):110-25. PubMed ID: 26096457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design of the Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography IMaging (PARADIGM) registry: A comprehensive exploration of plaque progression and its impact on clinical outcomes from a multicenter serial coronary computed tomographic angiography study.
    Lee SE; Chang HJ; Rizvi A; Hadamitzky M; Kim YJ; Conte E; Andreini D; Pontone G; Volpato V; Budoff MJ; Gottlieb I; Lee BK; Chun EJ; Cademartiri F; Maffei E; Marques H; Leipsic JA; Shin S; Choi JH; Chung N; Min JK
    Am Heart J; 2016 Dec; 182():72-79. PubMed ID: 27914502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hs-Troponin I Followed by CT Angiography Improves Acute Coronary Syndrome Risk Stratification Accuracy and Work-Up in Acute Chest Pain Patients: Results From ROMICAT II Trial.
    Ferencik M; Liu T; Mayrhofer T; Puchner SB; Lu MT; Maurovich-Horvat P; Pope JH; Truong QA; Udelson JE; Peacock WF; White CS; Woodard PK; Fleg JL; Nagurney JT; Januzzi JL; Hoffmann U
    JACC Cardiovasc Imaging; 2015 Nov; 8(11):1272-1281. PubMed ID: 26476506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cause or effect of arteriogenesis: compositional alterations of microparticles from CAD patients undergoing external counterpulsation therapy.
    Al Kaabi A; Traupe T; Stutz M; Buchs N; Heller M
    PLoS One; 2012; 7(10):e46822. PubMed ID: 23056467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the relation between the calcium score and plaque characteristics in patients with acute coronary syndrome versus patients with stable coronary artery disease, assessed by computed tomography angiography and virtual histology intravascular ultrasound.
    van Velzen JE; de Graaf FR; Jukema JW; de Grooth GJ; Pundziute G; Kroft LJ; de Roos A; Reiber JH; Bax JJ; Schalij MJ; Schuijf JD; van der Wall EE
    Am J Cardiol; 2011 Sep; 108(5):658-64. PubMed ID: 21684509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.